Recursion Pharmaceuticals is helping pioneer the use of AI in drug discovery. The company's operating system tests ...

Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

Balancing nitrogen use is critical for maximizing crop yield while minimizing environmental and economic costs. A new approach integrates drone-based ...

Overview: Strong knowledge of data structures and recognizing common patterns makes complex coding questions easier and faster to solve.Thinking out loud during ...

We are approaching the integration of artificial intelligence into our universities in a piecemeal rather than a comprehensive fashion.

As the program engages more directly with global concerns such as the climate crisis, he will lead the way.

IntroductionIn December 2025, Zscaler ThreatLabz discovered a campaign linked to APT37 (also known as ScarCruft, Ruby Sleet, and Velvet Chollima), which is a DPRK-backed threat group. In this campaign ...

Information concerning registration for the LRA 2026 conference, which will include a keynote address by Dr. Yolanda Sealey-Ruiz, is expected to be released shortly on the Literacy Research ...

Running a local DNS server is great - until your devices ignore it ...